The Combined Use of Hydroxymethylbutyrate and Branched-Chain Amino Acids to Counteract Uremic Sarcopenia
In HD patients, this FFSMP produced favorable changes in markers of muscle mass and systemic inflammation without affecting short-term physical performance. These findings support the potential clinical utility of targeted amino acid supplementation in this patient population, highlighting the need for larger, longer-term trials.
Authors
- Annalisa Noce
- Anna Paola Mitterhofer (ORCID: https://orcid.org/0000-0002-0132-386X)
- Giulia Marrone (ORCID: https://orcid.org/0000-0002-5854-2086)
- Roberto Palumbo (ORCID: https://orcid.org/0000-0003-1569-1812)
- Manuela Di Lauro (ORCID: https://orcid.org/0000-0001-8118-1330)
- Kevin Cornali (ORCID: https://orcid.org/0009-0004-8904-4399)
- Gabriele D’Urso
- Sabri Shamsan Hassan
- Sara Dominijanni
- Luca Di Marco
Institutions
- University of Rome Tor Vergata (IT)
- University of Verona (IT)
- Policlinico Tor Vergata (IT)
- St. Eugenio Hospital (IT)
- Ospedale SS. Annunziata (IT)
Publication Details
- Journal
- Nutrients
- Published
- 2026-02-01
- DOI
- https://doi.org/10.3390/nu18030483
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00